Hyperglycemia, lipid metabolism disorders, and abnormalities in the insulin signaling pathway are widely recognized as the initiating factors underlying various pathophysiological changes in DRN (Figure 3A–D). The gene discussed is INS; the disease is Hyperglycemia.